Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2009-05-18Clinical Trial Update: A Study of Aripiprazole in Patients With Major Depressive Disorder [Phase 3]
A Phase 3 clinical trial evaluating aripiprazole in major depressive disorder has completed and its results were posted.
-
CLINICAL_TRIALS trial_result · 2009-05-13Clinical Trial Update: Efficacy of Paroxetine in the Prevention of Depressive Syndrome in Patients With Chronic Hepatitis C Treated by PEG-Interferon Alfa Plus Ribavirin [Phase 3]
A Phase 3 trial assessed whether paroxetine can prevent depressive syndrome in patients with chronic hepatitis C treated with pegylated inte…
-
CLINICAL_TRIALS trial_result · 2009-05-13Clinical Trial Update: Lamotrigine Augmentation in Resistant Depression [NA]
A completed clinical trial evaluated lamotrigine augmentation in treatment-resistant major depressive disorder.
-
CLINICAL_TRIALS research · 2009-05-04Clinical Trial Update: Prevalence and Recognition of Geriatric Syndrome in Outpatient Clinic at Srinagarind Hospital
This clinical trial update examines the prevalence and recognition of geriatric syndromes in outpatient patients at Srinagarind Hospital, co…
-
FDA approval · 2009-04-23FDA Approved: PRISTIQ EXTENDED-RELEASE — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
FDA approved a supplemental application for Pristiq Extended-Release (desvenlafaxine succinate) from Wyeth Pharmaceuticals (a Pfizer subsidi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2009-04-21FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Granules Pharmaceuticals Inc.)
FDA approved a supplemental application for sertraline hydrochloride from Granules Pharmaceuticals Inc., indicating approval of a modificati…
-
CLINICAL_TRIALS trial_result · 2009-04-13Clinical Trial Update: An Eight-Week Study Evaluating the Efficacy and Tolerability of Two Doses of SSR149415 in Outpatients With Major Depressive Disorder [Phase 2]
A Phase 2 study evaluating two doses of SSR149415 in outpatients with major depressive disorder has completed, summarizing the efficacy and …
-
FDA approval · 2009-04-06FDA Approved: CITALOPRAM — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for a generic citalopram product from Hikma Pharmaceuticals USA Inc.
-
FDA approval · 2009-04-06FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for venlafaxine hydrochloride from Dr. Reddy's Laboratories Limited, approving changes related to th…
-
CLINICAL_TRIALS research · 2009-04-03Clinical Trial Update: Effect of Partial Sleep Deprivation on Cognition and Cytokines in Individuals With Major Depression [Phase 4]
A Phase 4 clinical trial examining whether partial sleep deprivation affects cognitive function and cytokine levels in individuals with majo…
-
CLINICAL_TRIALS trial_result · 2009-04-02Clinical Trial Update: Compare the Efficacy and Tolerability of the Combination of Aripiprazole and Selective Serotonin Reuptake Inhibitors (SSRIs) Used in Major Depression [NA]
A completed clinical trial evaluated the efficacy and tolerability of combining aripiprazole with SSRIs for major depressive disorder.
-
CLINICAL_TRIALS research · 2009-04-01Clinical Trial Update: Genetics of Fibromyalgia
This clinical trial update reports a genetics study led by the National Institute of Arthritis and Musculoskeletal and Skin Diseases investi…
-
FDA label_change · 2009-03-30FDA Approved: FLUOXETINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for Fluoxetine from Teva Pharmaceuticals USA, Inc., updating the labeling of the approved product.
-
CLINICAL_TRIALS trial_result · 2009-03-25Clinical Trial Update: Efficacy and Safety of One Single Dose of SR58611 Compared to Placebo and Paroxetine [Phase 3]
Phase 3 randomized trial assessing the efficacy and safety of a single dose of SR58611 compared with placebo and paroxetine in major depress…
-
CLINICAL_TRIALS trial_result · 2009-03-25Clinical Trial Update: Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo and Active Control in Major Depressive Disorder [Phase 3]
A Phase 3 clinical trial evaluating the safety and efficacy of quetiapine fumarate (SEROQUEL) versus placebo and an active control in adults…
-
CLINICAL_TRIALS trial_result · 2009-03-25Clinical Trial Update: Efficacy and Safety of SR58611A in Patients With Major Depressive Disorder (SIRIUS) [Phase 3]
Phase 3 trial update reports on efficacy and safety of SR58611A in adults with major depressive disorder (SIRIUS).
-
CLINICAL_TRIALS trial_result · 2009-03-25Clinical Trial Update: Efficacy and Safety of SR58611A co-Administered With Escitalopram in Adults With Major Depressive Disorder [Phase 3]
Phase 3 trial evaluating the efficacy and safety of SR58611A co-administered with escitalopram in adults with major depressive disorder. The…
-
CLINICAL_TRIALS trial_result · 2009-03-25Clinical Trial Update: Efficacy and Safety of Quetiapine Fumarate Sustained Release (SEROQUEL SR) in the Treatment of Major Depressive Disorders [Phase 3]
Phase 3 trial update reporting the efficacy and safety of quetiapine fumarate sustained release (SEROQUEL SR) for major depressive disorder.
-
CLINICAL_TRIALS trial_result · 2009-03-25Clinical Trial Update: Efficacy and Safety of SR58611 Compared to Placebo and Paroxetine [Phase 3]
Phase 3 trial investigating the efficacy and safety of SR58611 versus placebo and paroxetine in major depressive disorder; the document prov…
-
CLINICAL_TRIALS trial_result · 2009-03-25Clinical Trial Update: Efficacy of SEROQUEL in Selective Serotonin Reuptake Inhibitors (SSRI)-Resistant Major Depressive Disorder [Phase 2]
Phase 2 trial examining the efficacy of SEROQUEL (quetiapine) as an adjunct to SSRI therapy in patients with SSRI-resistant major depressive…
-
CLINICAL_TRIALS trial_result · 2009-03-25Clinical Trial Update: Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo in Major Depressive Disorder [Phase 3]
Phase 3 randomized, placebo-controlled trial assessing the safety and efficacy of quetiapine fumarate (SEROQUEL) versus placebo in adults wi…
-
CLINICAL_TRIALS trial_result · 2009-03-25Clinical Trial Update: Efficacy and Safety of Quetiapine Fumarate Sustained Release (SEROQUEL SR) in Combination With an Antidepressant in the Treatment of Major Depressive Disorders [Phase 3]
A Phase 3 trial evaluating the efficacy and safety of adding quetiapine fumarate sustained-release (SEROQUEL SR) to antidepressant therapy f…
-
CLINICAL_TRIALS trial_result · 2009-03-25Clinical Trial Update: Long Term Safety and Tolerability of SR58611 in Patients With Major Depressive Disorder [Phase 3]
The document reports long-term safety and tolerability results from a Phase 3 trial of SR58611 in adults with major depressive disorder.
-
CLINICAL_TRIALS trial_result · 2009-03-25Clinical Trial Update: Quetiapine Fumarate as Monotherapy in the Maintenance Treatment of Patients With Major Depressive Disorder [Phase 3]
Phase 3 trial evaluating quetiapine fumarate as monotherapy for maintenance treatment in adults with major depressive disorder has completed…
-
FDA approval · 2009-03-24FDA Approved: BUPROPION HYDROCHLORIDE SR — Original Application (Actavis Pharma, Inc.)
FDA approved a generic sustained-release formulation of bupropion hydrochloride for major depressive disorder and seasonal affective disorde…